Asymchem Laboratories (Tianjin) Co., Ltd. Stock

Stocks

002821

CNE100002BZ6

Pharmaceuticals

OTC Markets Traded
End-of-day quote 21/08/2026 5-day change 1st Jan Change
168.10 CNY -7.84% Intraday chart for Asymchem Laboratories (Tianjin) Co., Ltd. -1.81% +80.89%

Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 58.63B 8.72B 7.47B 6.99B 6.4B 12.01B 835B 12.17B 82.59B 32.21B 419B 32.75B 32.04B 1,387B P/E 2026 *
43.2x
P/E 2027 * 34.3x
Enterprise Value 53.58B 7.97B 6.83B 6.39B 5.85B 10.98B 763B 11.12B 75.48B 29.44B 383B 29.93B 29.28B 1,267B EV / Sales 2026 *
6.63x
EV / Sales 2027 * 5.58x
Free-Float
61.13%
Yield 2026 *
0.87%
Yield 2027 * 1.07%
07-31 Asymchem Laboratories to Subscribe for Subsidiary's New Shares for 1.05 Billion Yuan; Shares Up 6% MT
07-30 Shanghai Asymchem Biotechnology Development Co., Ltd. announced that it expects to receive CNY 1.239699995 billion in funding from Asymchem Laboratories Co., Ltd., Suzhou Gao Ling Qirui Healthcare Investment, L.P. and another investor CI
07-27 AsymBio, Subsidiary of Asymchem Group Kicks Off Construction of Fengxian R&D Building CI
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy MT
07-10 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$131.48 From HK$115.43, Keeps at Buy MT
06-11 Asymchem Laboratories Co., Ltd. Approves Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on June 26, 2026 CI
05-27 Asymbio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates CI
05-20 Citigroup's long position in H shares of Asymchem Laboratories (Tianjin) decreases to 4.99% on May 14 from 5.66%, HKEX filing says RE
05-15 Asymchem Laboratories Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2025, Payable on 24 July 2026 CI
05-13 Citigroup's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 5.36% on May 7, HKEX says RE
05-04 JPMorgan Chase's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 7.64% on Apr 28 from 8.18%, HKEX filing shows RE
04-28 Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8% MT
04-27 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
1 day-7.84%
1 week-1.81%
Current month+10.12%
1 month+2.33%
3 months+32.52%
6 months+67.13%
Current year+80.89%
1 week 166.22
Extreme 166.22
187.65
1 month 142.43
Extreme 142.43
188
Current year 91.33
Extreme 91.33
200
1 year 88.46
Extreme 88.46
200
3 years 59.55
Extreme 59.55
200
5 years 59.55
Extreme 59.55
380.35
10 years 13.09
Extreme 13.085713
380.35
Manager TitleAgeSince
Chief Executive Officer 70 07/10/1998
Chief Executive Officer 49 19/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 18/07/2011
Chairman 70 07/10/1998
Director/Board Member 65 18/07/2011
Date Insider Type Main position Quantity % Market Cap.
14/07/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany -315,000 1.1317%
08/07/26 Other

Chief Executive Officer

25,000 0.0898%
08/07/26
Tianjin Guorong Business Information Consulting Co. Ltd.
OtherCompany 25,000 0.0898%
Change 5-day change 1-year change 3-year change Capi.($)
-7.84%-1.81%+57.84%+39.28% 8.72B
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +0.38%+3.97%+34.12%+52.03% 380.86B
Weighted average by Cap. +1.12%+5.07%+44.29%+72.57%

Financials

2026 *2027 *
Net sales 8.08B 1.2B 1.03B 964M 882M 1.66B 115B 1.68B 11.38B 4.44B 57.78B 4.51B 4.42B 191B 9.72B 1.45B 1.24B 1.16B 1.06B 1.99B 138B 2.02B 13.69B 5.34B 69.51B 5.43B 5.31B 230B
Net income 1.4B 209M 179M 167M 153M 287M 19.96B 291M 1.98B 770M 10.02B 783M 766M 33.16B 1.77B 263M 225M 211M 193M 362M 25.18B 367M 2.49B 972M 12.65B 988M 967M 41.84B
Net Debt -5.05B -751M -643M -602M -551M -1.03B -71.87B -1.05B -7.11B -2.77B -36.1B -2.82B -2.76B -119B -4.39B -653M -560M -524M -479M -900M -62.51B -912M -6.19B -2.41B -31.4B -2.45B -2.4B -104B
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Date Price Change Volume
21/08/26 CN¥168.10 -7.84% 20,533,769
20/08/26 CN¥182.40 +6.92% 24,967,150
19/08/26 CN¥170.59 -3.76% 11,994,036
18/08/26 CN¥177.25 +0.07% 10,432,929
17/08/26 CN¥177.12 +3.46% 12,059,671
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
168.10CNY
Average target price
160.45CNY
Spread / Average Target
-4.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002821 Stock